Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.28
+0.37 (3.73%)
At close: Jul 1, 2026, 4:00 PM EDT
10.30
+0.02 (0.19%)
Pre-market: Jul 2, 2026, 8:49 AM EDT
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 485 employees as of December 31, 2025. The number of employees decreased by 349 or -41.85% compared to the previous year.
Employees
485
Change (1Y)
-349
Growth (1Y)
-41.85%
Revenue / Employee
$312,163
Profits / Employee
-$627,614
Market Cap
671.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 485 | -349 | -41.85% |
| Dec 31, 2024 | 834 | -384 | -31.53% |
| Dec 31, 2023 | 1,218 | -74 | -5.73% |
| Dec 31, 2022 | 1,292 | 651 | 101.56% |
| Dec 31, 2021 | 641 | 146 | 29.49% |
| Mar 31, 2021 | 495 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| 4D Molecular Therapeutics | 196 |
| CorMedix | 191 |
| Omeros | 175 |
| SpyGlass Pharma | 68 |
| Achieve Life Sciences | 28 |
| Immix Biopharma | 21 |
| Relmada Therapeutics | 17 |
DNA News
- 5 weeks ago - Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery - PRNewsWire
- 7 weeks ago - Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M) - TheFly
- 7 weeks ago - Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Ginkgo Bioworks Holdings Earnings release: Q1 2026 - Filings
- 7 weeks ago - Ginkgo Bioworks Holdings Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Ginkgo Bioworks Holdings Slides: Q1 2026 - Filings
- 7 weeks ago - Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab - PRNewsWire
- 2 months ago - Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation - PRNewsWire